SGLT2i as a Useful Adjunctive Medication for HNF4A-MODY. Suzuki S, Kokumai T, Furuya A, Takahashi S, et al. Diabetes Care 2023;46:e74-e75.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Suzuki S, Kokumai T, Furuya A, Takahashi S, et al. SGLT2i as a Useful Adjunctive Medication for HNF4A-MODY. Diabetes Care 2023;46:e74-e75.
PMID: 36598838